Gastroesophageal Reflux in Children Clinical Trial
Official title:
Study on the Efficacy and Tolerance of a New Anti-regurgitation Infant Formula: a Double-blind, Randomized, Controlled, International, Multi-centric Clinical Trial
The aim of the study is to assess the effectiveness of this new formula on regurgitations and secondarily its effect on digestive tolerance through a randomized, controlled, double-blind trial against a comparator.
The study duration is 1 month and 2 days. It is possible to add 2 additional months
(optional).
The 2 first days (from D-3 to D0) correspond to the pre-selection period. These 2 days are
followed by the follow-up month (from D0 to D30). It is possible to add an optional follow up
of 2 months (form D30 to D90).
;